Trials / Completed
CompletedNCT03039426
Postoperative Cesarean Delivery Pain Relief; Diclofenac Versus Bupivacaine
A Randomized Comparison of Bupivacaine Peritoneal and Subcutaneous Infiltration Versus Diclofenac Intramuscular Injection for Postoperative Pain Relief in Patient Undergoing Cesarean Delivery
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 120 (actual)
- Sponsor
- Department of Medical Services Ministry of Public Health of Thailand · Other Government
- Sex
- Female
- Age
- 20 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
This randomized controlled trial, compared postoperative pain score in patient undergoing cesarean delivery between bupivacaine peritoneal and subcutaneous infiltration and diclofenac intramuscular injection
Detailed description
Postoperative cesarean delivery was painful that can effect daily activity, resulted in poor quality of life and required morphine injection to relief pain which had both maternal and breastfeeding infancy side effect. So this study compare efficacy of diclofenac and bupivacaine by measured the pain score and requirement of morphine injection.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bupivacaine | 0.5% bupivacaine 20ml divided in two; 10 ml intraperitoneal infiltration and 10 ml subcutaneous infiltration |
| DRUG | Diclofenac | diclofenac 75 mg intramuscular, 2 hours postoperation |
Timeline
- Start date
- 2017-01-01
- Primary completion
- 2017-06-30
- Completion
- 2017-12-30
- First posted
- 2017-02-01
- Last updated
- 2020-10-22
Locations
2 sites across 1 country: Thailand
Source: ClinicalTrials.gov record NCT03039426. Inclusion in this directory is not an endorsement.